Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?

Document Details

Document Type
Pub Defense Publication
Publication Date
Aug 01, 2016
Source ID
10.1016/j.jtho.2016.04.018

Entities

People

  • Julien Sage
  • Sandra Cristea

Organizations

  • Lustgarten Foundation for Pancreatic Cancer Research
  • United States Department of Defense